INTRODUCTION
Acute myeloid leukemia (AML) is a clonal hematologic disease characterized by uncontrolled proliferation and abnormal survival of immature myeloid progenitors [1] . Leukemia cells are unable to undergo growth arrest, terminal differentiation, and apoptosis in response to appropriate stimulation [2] . The standard therapeutic approach to AML is chemotherapy, either via monotherapy or combination treatment with drugs such as anthracycline, doxorubicin, or idarubicin. However, the prognosis of AML remains unsatisfactory.
Moreover, standard chemotherapy is highly toxic and poorly tolerated [3] . Thus, it is necessary to develop novel therapeutic agents to improve the cure rate in AML.
The medicinal herb Danshen (Salvia miltiorrhiza Bunge) has been widely used in traditional Chinese medicine treatment for over 1,000 years. Cryptotanshinone (CPT) is a major constituent of tanshinones, which are extracted from Danshen, and has well-documented antioxidative and anti-inflammatory effects [4] . In addition, recent studies have shown that CPT could induce apoptosis in several kinds of solid tumor [5] [6] [7] , which makes it a potential anticancer agent. However, there is a paucity of research on the effect of CPT on leukemia.
In this study, we have examined the effects of CPT on HL-60, a human leukemia cell line, and studied the mechanisms involved.
EXPERIMENTAL

Chemicals and reagents
Cryptotanshinone was purchased from LKT Laboratories (St. Paul, MN, USA). The purity was verified by high performance liquid chromatography. CPT was dissolved in DMSO and stored at -20 o C. An Annexin V-FITC/PI Apoptosis Kit was purchased from BioSource (CA, USA). 5,5',6,6'-Tetrachloro-1,1',3,3'-tetraethylbenzimidazolyl-carbocyanine iodide (JC-1) was purchased from Molecular Probes Incorporated (Eugene, OR, USA). Hoechst 33342 was purchased from Invitrogen (CA, USA). Caspase-3, -8, and -9 protease activity was determined by a Biovision kit (CA, USA), a pan-caspase inhibitor (Z-VAD-FMK). Specific caspase inhibitors for caspase-3 (Z-DEVD-FMK) and -9 (Z-LEHD-FMK) were purchased from Calbiochem (Merck, CA, USA). Antibodies Bax and Bcl-2 were purchased from Santa Cruz Biotechnology Inc (CA, USA).
Cell line and culture
The HL-60 (human acute promyelocytic leukemia) cell line was purchased from American Type Culture Collection (Rockville, MD, USA). The cells were maintained in RPMI-1640 medium (Gibco, USA) containing 10% fetal bovine serum (Gibco, USA) and 1% penicillin-streptomycin (Gibco, USA) at 37 o C in a humidified atmosphere of 5% CO 2 .
Growth inhibition assay
The effect of CPT on cell growth inhibition was measured by a MTT assay based on the enzymatic reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (Sigma, MO, USA) to form formazan crystals. Cells (10 4 /well) were grown on a 96-well microliter plate and incubated with or without CPT (0 -20 µg/ml) in RPMI-1640/10% fetal bovine serum. After 48 h, 30 µl MTT solution (5 mg/ml PBS) was added to each well and incubation was continued for 4 additional hours. Cell growth inhibition (%) was calculated by measuring mass spectrometric absorbance at 540 nm.
Analysis of morphological changes
After treatment, HL-60 cells were washed with PBS, fixed with 70% ethanol, and stained with Hoechst 33342. Morphological changes were analyzed with fluorescence microscope.
Flow cytometric analysis of apoptosis
HL-60 cells (1 × 10 6 cells /well) were cultured in a 6-well plate in the absence or presence of CPT for 24 h. After washing the cells twice with cold PBS, cell pellets were resuspended in 100 μl of labeling solution containing Annexin V-FITC and PI, followed by 15 min incubation in the dark at room temperature. Apoptotic cells were detected by a FACS Calibur flow cytometer (Becton Dickinson).
Cell cycle analysis
After treatment with CPT for 24 h, cells were briefly washed with PBS and harvested. Cell pellets were stained with 1 ml DNA staining solution (20 μg/ml of PI and 100 μg/ml of RNaseA in PBS) in the dark at 37°C for 30 min. Percentages of cells within each phase of the cell cycle (G0-G1, S, G2-M) were determined by flow cytometry.
Caspase activity assay
Caspase protease activity was determined by caspase-3, caspase-8, and caspase-9 Colorimetric Assay Kit (Biovision, San Francisco, USA). Treated cells were re-suspended in lysis buffer, incubated on ice, centrifuged, received reaction buffer and specific caspase protease substrate, incubated at 37°C for 1 -2 h, then analyzed at 405 nm in a microplate reader (Model 680, BioRad).
Mitochondrial membrane potential assay
CPT-treated cells were harvested with PBS washing and re-suspended in 1 ml PBS containing 10 μM JC-1 staining dye at 37°C for 15 min. After centrifuging, cell pellets were resuspended in 1 ml PBS and analyzed by flow cytometry.
Western blot analysis
Control and CPT-treated HL-60 cells were collected and lysed at indicated times with lysis buffer containing 0.1 mol/L EDTA, 0.05 mol/L EGTA, 2 mol/L NaCl, 1 mol/L Tris-HCl, pH 6.8, 0.5% NP-40 and 10 mmol/L PMSF. Protein concentration was measured by Bradford method. Cell lysates containing 50μg of total cellular protein were fractionated in 12.5% SDSpolyacrylamide gels. Separated proteins were transferred to a polyvinylidene fluoride (PVDF) membrane (Millipore, USA) and incubated with primary antibodies, then visualized with horseradish peroxidase-conjugated secondary antibody (Santa Cruz, CA, USA). Primary antibodies used and their dilution ratios were: p53 (1:2000), p21 (1:500), Bax (1:1000), poly (adenosine diphosphate-ribose) polymerase (PARP) (1:2000), cytochrome C (1:1000), and GAPDH (1:5000). All these primary antibodies were purchased from Santa Cruz.
Statistical analysis
All data are expressed as the mean ± standard deviation (SD). One-way analysis of variance (ANOVA) was performed to determine if any difference existed between groups. All analyses were performed by Graphpad Prism 5. p < 0.05 was considered to be statistically significant.
RESULTS
The CPT inhibited HL-60 cell growth and induced morphological changes CPT showed significant growth inhibition on HL-60 cells in a dose-dependent (p < 0.0001) and time-dependent manner (p < 0.0001) by MTT assay (Figure 1 ). 
CPT-induced apoptosis in HL-60 cells
In addition to apoptosis in morphology as mentioned above, Annexin V/PI staining assay demonstrated that the apoptosis percentage of HL-60 cells increased in a dose-dependent manner (p < 0.01) after treatment with CPT for 24 hours, reaching 13.76 and 22.48% at CPT concentrations of 2.5 and 5 μg/ml, respectively (Figure 3 ).
CPT induced G0/G1 phase arrest and apoptosis of HL-60 cells
Compared to untreated cells, HL-60 cells treated with 5µg/ml CPT were arrested in the G0/G1 phase significantly ( Figure 4A ). Furthermore, a significant increase of the sub-G1 population was observed ( Figure 4B ), confirming that CPT induced dose-dependent apoptosis in these cells (p < 0.01). Western blot analysis of cell lysates obtained from HL-60 cells indicated that the CPT-induced arrest in G0/G1 phase was paralleled by the accumulation of p53 and p21 proteins ( Figure 4C ). 
CPT activated caspase-3, -8 and -9 in HL-60
CPT treatment resulted in a significant increase in caspase-3, -8 and -9 activity compared to control group (p < 0.01, Figure 5A ). The pancaspase inhibitor, zVAD-FMK, and two specific caspase inhibitors, Z-DEVD-FMK for caspase-3 and Z-LEHD-FMK for caspase-9, could partially abrogate CPT-induced cell death in HL-60 cells ( Figure 5B ). The pan-caspase inhibitor zVAD-FMK increased cell viability by up to 61%. 
CPT triggered cytochrome c release and PARP cleavage
HL-60 cells treated with CPT were also found to have increasing levels of cytochrome c in the cytosol in a dose-dependent manner (Figure 7) . In mitochondria pathway, PARP cleavage is subsequent to casepase-3 activation after casepase-9 activation by cytochrome c release. Thus, in our study, additional evidence of caspase-3 activation was the cleavage of PARP as investigated by Western blot analysis ( Figure  7 ).
DISCUSSION
CPT is a natural compound with potential anticancer effect. Recent studies have shown that CPT inhibited proliferation and induced [5, 7, 8] . The mechanisms involved are arresting cell cycle in G0/G1 phase, downregulation of cyclin D1 expression, hypophosphorylation of Rb, inhibition of STAT3, endoplasmic reticulum stress and et al. However, there is lack of reports on leukemia cells. In this study, we demonstrated that HL-60 cells, a Human promyelocytic leukemia cell line, undergo apoptosis when treated with varying concentrations of CPT. In the MTT assay, CPT showed significant growth inhibition of HL-60 cells. Further investigation showed that CPT exhibited both dose-dependent and timedependent inhibition of cell proliferation in HL-60 cells, by causing G0/G1 arrest. Cell cycle arrest Control 1.25g/ml 2.5g/ml 5 g/ml CPT in CPT-treated cells was accompanied by a marked increase in the level of sub-G1 phase cells, which reflects the proportion of apoptotic cells (Figures 1, 4) . Moreover, the study also demonstrated CPT induced the accumulation of p53 and p21, indicating p53 and p21 proteins activate the transcription of genes encoding for factors involved in G1 to S-phase transition.
Sub-GI
Apoptosis is a programmed, essential process of cell death that allows for the removal of damaged cells in order to maintain tissue homeostasis. Classical apoptosis can be mediated by two pathways: the mitochondrial (intrinsic) pathway and the death receptor (extrinsic) pathway [9, 10] . The mitochondrial pathway is controlled by members of Bcl-2 family proteins comprising both pro-apoptotic proteins (Bax, Bak, and Bid) and anti-apoptotic proteins (Bcl-2 and Bcl-xL) [11, 12] . The balance between pro-and antiapoptotic proteins determines the fate of cells [13] , which is always followed by the loss of MMP, release of cytochrome C [14] , and activation of caspase [15] . In our study, the expression of Bax proteins were upregulated and levels of Bcl-2 proteins were downregulated by CPT treatment in a dose-dependent manner. It suggested that decrease of Bcl-2/Bax play important role in apoptosis of HL-60 cells induced by CPT.
Mitochondria acts as a point of integration for apoptotic signals, as both intrinsic and extrinsic pathways trigger the disruption of mitochondrial membrane permeability. Our data demonstrated that CPT treatment leads to a dose-dependent collapse of MMP, which was subsequent to Bcl-2/Bax decrease. Cytochrome c is a key factor which is released from the mitochondria into the cytosol during apoptosis [16] . When mitochondria membrane permeability increases after loss of MMP, cytochrome c releases from mitochondria, which leads to caspase-9 activation, which subsequently activates caspase-3 [17] . Here, we demonstrated that CPT induced the release of cytochrome c from the mitochondria to the cytosol in HL-60 cells in a time-dependent manner. These results suggest that CPT induces HL-60 apoptosis through a mitochondrialdependent pathway.
Both extrinsic and intrinsic pathways are regulated by caspases, which are responsible for cascade activation during apoptosis, induced by many stimuli [18] . Activation of caspase initiators (procaspases 8-10) leads to proteolytic activation of downstream effector caspases (caspase-3, -6, -7). In our study, CPT increased the activity of caspase-3, -8, and -9 in a time-dependent manner, and pretreatment with pan-caspase inhibitors or casepase-3, -9 specific inhibitors could partially have prevented CPT-induced HL-60 cell death ( Figure 5 ). Therefore, casepase-3, -8 and -9 was important executor in apoptosis of HL-60 cells induced by CPT.
CONCLUSION
It has been demonstrated in this study that CPT effectively induces apoptosis of HL-60 cells, which starts with decrease of Bcl-2/Bax ratio, followed by loss of MMP, release of cytochrome C, activation of caspase-3, -8, and -9, cleavage of PARP. Meanwhile, arrest of G0/G1 phase occurs due to accumulation of p53 and p21. These findings suggest CPT might be a potential therapeutic and chemopreventive agent for leukemia, but further in vitro and in vivo experiments should be carried out to ascertain this.
